Tilt Investment Management Holdings PBC Sells 1,797 Shares of Humana Inc. (NYSE:HUM)

Tilt Investment Management Holdings PBC cut its stake in Humana Inc. (NYSE:HUM) by 78.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 508 shares of the insurance provider’s stock after selling 1,797 shares during the quarter. Tilt Investment Management Holdings PBC’s holdings in Humana were worth $233,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in the stock. Wright Investors Service Inc. bought a new stake in shares of Humana in the fourth quarter worth approximately $494,000. Livforsakringsbolaget Skandia Omsesidigt grew its stake in shares of Humana by 2.9% in the fourth quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 4,427 shares of the insurance provider’s stock worth $2,029,000 after acquiring an additional 124 shares during the period. Daiwa Securities Group Inc. grew its stake in shares of Humana by 25.5% in the fourth quarter. Daiwa Securities Group Inc. now owns 17,021 shares of the insurance provider’s stock worth $7,792,000 after acquiring an additional 3,458 shares during the period. Rakuten Securities Inc. bought a new stake in shares of Humana in the fourth quarter worth approximately $25,000. Finally, Tyche Wealth Partners LLC bought a new stake in shares of Humana in the fourth quarter worth approximately $271,000. 92.38% of the stock is currently owned by institutional investors.

Insider Activity

In related news, Director Jorge S. Mesquita bought 545 shares of the stock in a transaction dated Tuesday, February 20th. The stock was purchased at an average cost of $367.09 per share, with a total value of $200,064.05. Following the completion of the purchase, the director now owns 2,578 shares of the company’s stock, valued at $946,358.02. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 0.32% of the company’s stock.

Wall Street Analysts Forecast Growth

HUM has been the topic of a number of research reports. Argus downgraded shares of Humana from a “buy” rating to a “hold” rating in a report on Wednesday, March 13th. Raymond James initiated coverage on shares of Humana in a report on Friday, March 22nd. They issued a “market perform” rating on the stock. Stephens dropped their price objective on shares of Humana from $550.00 to $430.00 and set an “overweight” rating on the stock in a report on Friday, January 26th. The Goldman Sachs Group dropped their price objective on shares of Humana from $450.00 to $385.00 and set a “buy” rating on the stock in a report on Wednesday, April 3rd. Finally, StockNews.com downgraded shares of Humana from a “strong-buy” rating to a “hold” rating in a report on Friday, January 26th. Eleven investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $465.42.

Humana Stock Up 0.4 %

Shares of HUM opened at $324.83 on Friday. The firm has a market capitalization of $39.19 billion, a P/E ratio of 16.39, a P/E/G ratio of 1.90 and a beta of 0.45. Humana Inc. has a 12-month low of $299.23 and a 12-month high of $541.21. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.63. The firm has a fifty day moving average price of $343.55 and a 200-day moving average price of $425.01.

Humana (NYSE:HUM) last issued its earnings results on Thursday, January 25th. The insurance provider reported ($0.11) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.76 by ($0.87). The company had revenue of $26.46 billion for the quarter, compared to analysts’ expectations of $25.47 billion. Humana had a net margin of 2.34% and a return on equity of 19.44%. The firm’s revenue for the quarter was up 17.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.62 earnings per share. Equities research analysts expect that Humana Inc. will post 16.06 earnings per share for the current year.

Humana Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.09%. Humana’s dividend payout ratio is currently 17.86%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.